New study tracks hidden dangers of CAR t therapy in kids

NCT ID NCT06579469

Recruiting now Knowledge-focused Sponsor: St. Jude Children's Research Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 100 children and young adults who received CAR T cell therapy to understand short- and long-term side effects like infections, slow blood cell recovery, and nerve problems. Researchers will check participants at 3, 6, 12, and 24 months after treatment. The goal is to better manage these side effects and improve care for future patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for B-ALL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

B-cell acute lymphoblastic leukemia hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm precursor B-cell acute lymphoblastic leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

B-ALL HEMATOLOGIC MALIGNANCY SOLID TUMOR

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Children's Hospital of Philadelphia
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Children's Hospital of Wisconsin.
RECRUITING

Milwaukee, Wisconsin, 53226, United States
Childrens Hospital of Colorado
RECRUITING

Aurora, Colorado, 80045, United States
Primary Children's Hospital
RECRUITING

Salt Lake City, Utah, 84113, United States
Seattle Childrens Hospital
RECRUITING

Seattle, Washington, 98105, United States
St. Jude Children's Research Hospital
RECRUITING

Memphis, Tennessee, 38105, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.